A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
Titel:
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
Auteur:
O’Connor, R. O’Leary, M. Ballot, J. Collins, C. D. Kinsella, P. Mager, D. E. Arnold, R. D. O’Driscoll, L. Larkin, A. Kennedy, S. Fennelly, D. Clynes, M. Crown, J.